Prevalence of Psychotropic Medication Use and Psychotropic Polypharmacy in Autistic Adults With or Without Intellectual Disability
- 14 January 2024
- journal article
- research article
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 55 (2) , 457-471
Abstract
The aim of this study was to compare the rates of psychotropic medication use and psychotropic polypharmacy between autistic adults with and without intellectual disability (ID) and to examine factors associated with psychotropic medication use and psychotropic polypharmacy in autistic adults, stratified by the presence of ID. We conducted a retrospective medical chart review of outpatients with an autism diagnosis aged 18 years and older. The rates of psychotropic medication use and psychotropic polypharmacy were compared between autistic adults with and without ID. Subsequently, logistic regression analyses were performed to identify factors associated with psychotropic medication use and psychotropic polypharmacy in autistic adults with ID and those without ID, respectively. The rates of prevalence of psychotropic medication use and polypharmacy were significantly higher in participants with ID than those without ID (78.6% vs. 58.8% and 49.3% vs. 31.2%; p-values < 0.05). Age, gender, race, residence, presence of mood disorders, presence of schizophrenia, absence of anxiety disorder, number of psychiatric comorbidities, and presence of behaviors that challenge were significantly associated with these outcomes, depending on the presence/absence of ID. The need to optimize pharmacotherapy in autistic adults, stratifying by the presence of ID, is highlighted.Keywords
This publication has 45 references indexed in Scilit:
- Polypharmacy profiles and predictors among adults with autism spectrum disordersResearch in Autism Spectrum Disorders, 2012
- Issues in the Management of Challenging Behaviours of Adults with Autism Spectrum DisorderCNS Drugs, 2011
- Challenging behavior and co-morbid psychopathology in adults with intellectual disability and autism spectrum disordersResearch in Developmental Disabilities, 2010
- A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum DisordersJournal of Autism and Developmental Disorders, 2009
- Characteristics of challenging behaviours in adults with autistic disorder, PDD-NOS, and intellectual disabilityJournal of Intellectual & Developmental Disability, 2008
- Persistence of challenging behaviours in adults with intellectual disability over a period of 11 yearsJournal of Intellectual Disability Research, 2008
- Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum DisordersPediatrics, 2008
- A total population study of challenging behaviour in the county of Hedmark, Norway: Prevalence, and risk markersResearch in Developmental Disabilities, 2006
- Medication Patterns in Patients with Autism: Temporal, Regional, and Demographic InfluencesJournal of Child and Adolescent Psychopharmacology, 2005
- Psychiatric comorbidity and medication use in autism: a community surveyPsychiatric Bulletin, 2003